Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Thiotepa and Carboplatin for Recurrent CNS PNETs
NCT00025077Phase 2Completed
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of thiotepa and carboplatin in medulloblastoma, supratentorial primitive neuroectodermal tumor (sPNET) and pineal tumor, sponsored by Children's Cancer and Leukaemia Group. Primary endpoint: Event-free survival. Started Jan 2000; status: completed.
02
Drugs
thiotepacarboplatin
03
Conditions
medulloblastomasupratentorial primitive neuroectodermal tumor (sPNET)pineal tumor
Beyond the preview
Go deeper on NCT00025077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025077.